Diakine-DK2 10 (VEGFR2)

N/A

Report date: 2023/03/07 16:09:39

Base Information

Drug NameDiakine-DK2 10 (VEGFR2)

Drug Alias NameDiakine™- DK2 10 (VEGFR2)Diakine™- DK210 (VEGFR2)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInterleukin 10 receptor stimulantsInterferon alpha/beta receptor agonistsAnti-Vascular endothelial growth factor receptor 2

TargetsInterleukin-7 receptorsInterferon alpha/beta receptorVascular endothelial growth factor receptor 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A